| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Smith Nancy Freda, Director
Granted 25,000 Stock Option (right to buy) |
| 23 Jun 2026 |
Form 4: Angel Matthew, Director
Bought 231,482 shares ($500K) · Acquired 231,482 Series A Warrant (right to buy) (Open Market Purchase) · Acquired 231,482 Series B Warrant (right to buy) (Open Market Purchase) |
| 17 Jun 2026 |
Form 4: Yee John D., Director
Granted 25,000 Stock Option (right to buy) |
| 08 Jun 2026 |
Form 4: Richey William Drake, Director
Granted 25,000 Stock Option (right to buy) |
| 02 Apr 2026 |
Form 4: Trojanowski Justin, Corporate Controller
Granted 22,000 Employee Stock Option (right to buy) |
| 02 Apr 2026 |
Form 4: Maestas Nicholas, Chief Financial Officer
Granted 140,000 Employee Stock Option (right to buy) |
| 25 Mar 2026 |
Form 4: Angel Matthew, Director
Bought 231,482 shares ($500K) |
| 06 Feb 2026 |
Form 4: Angel Matthew, Director
Granted 269,621 Employee Stock Option (right to buy) |
| 28 Jan 2026 |
Form 4: Simantov Ronit, Director
Granted 1,230 Stock Option (right to buy) |
| 28 Jan 2026 |
Form 4: Raab Michael, Director
Granted 1,230 Stock Option (right to buy) |
| 28 Jan 2026 |
Form 4: Nichol Geoffrey, Director
Granted 1,230 Stock Option (right to buy) |
| 28 Jan 2026 |
Form 4: Pellizzari Christine A, Director
Granted 1,230 Stock Option (right to buy) |
| 06 Jan 2025 |
Form 4: Brady Stephen R, Director
Granted 550,000 Employee Stock Option (right to buy) |
| 06 Jan 2025 |
Form 4: Whiting Samuel, Chief Medical Officer
Granted 270,000 Employee Stock Option (right to buy) |
| 06 Jan 2025 |
Form 4: Trojanowski Justin, Corporate Controller
Granted 30,000 Employee Stock Option (right to buy) |
| 06 Jan 2025 |
Form 4: Maestas Nicholas, Chief Financial Officer
Granted 200,000 Employee Stock Option (right to buy) |
| 12 Aug 2024 |
Form 4: Versant Venture Capital VI, L.p., 10% owner and 8 others
Sold 400,000 shares ($540K) · Sold 387,999 shares ($427K) |
| 08 Jul 2024 |
Form 4: Brady Stephen R, Director
Bought 35,000 shares ($73.9K) |
| 03 Jul 2024 |
Form 4: Whiting Samuel, Chief Medical Officer
Bought 4,672 shares ($9.95K) |
| 02 Jul 2024 |
Form 4: Trojanowski Justin, Corporate Controller
Bought 7,500 shares ($16.2K) |
Loading...